Fact Based
-
Top therapeutic areas (TAs) expected to drive biopharma market growth, 2022-2028
-
Pharmacy Locations with Specialty Pharmacy Accreditation, by Corporate Ownership, 2022
-
Highlights from AAM's Generic & Biosimilar Medicines Savings Report
-
Clinical Management Strategies for Drug Shortages
-
KFF: Top 10 Drugs Accounting for 22% of Medicare Part D Total Gross Spending in 2021
-
PBM Market Share, by Total Equivalent Prescription Claims Managed, 2022
-
Wolters Kluwer Survey: 6 Pharmacy Consumer Insights
-
4 Findings: AHIP Research on Average Markups for Drugs Over Specialty Pharmacies
-
3 PBMs Partnered with Mark Cuban's Cost Plus Drug Company
-
7 Takeaways from Wolters Kluwer Survey: Health Consumer Medication Trends
-
PhRMA: Barriers and Burdens Standing Between Patients and Care, 4 Takeaways
-
Percentage of Individuals with Chronic Non-Cancer Pain Prescribed an Opioid, 2012-2019
-
Precedence Research: PBM Market Size, 2021 to 2030
-
ASHP Pharmacy Technician Shortage Survey, 6 Findings
-
AHIP Drug Cost Study, 4 Takeaways
-
Becker's: 4 Recent Pharmaceutical Purchases Made by U.S.
-
Top Five Pharmaceutical Companies by Sales and R&D Spending (2020 $US Dollars)
-
Top Ten U.S. Drugs (by sales) Losing Patent Exclusivity in 2021
-
National Medicare Prescription Drug Plan Enrollment for Past Five Years
-
Surescripts: What Lies Ahead For Pharmacists in 2021